Delaware | 000-17758 | 13-3306985 | ||
(State or other jurisdiction | (Commission | (I.R.S. Employer | ||
of incorporation) | File Number) | Identification No.) |
240 Cedar Knolls Road, Suite 200, Cedar Knolls, New Jersey |
07927 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 | Entry into a Material Definitive Agreement. |
Item 8.01 | Other Events |
Item 9.01 | Financial Statements and Exhibits. |
Exhibit No. | Description | |||
10.1 | Development and License Agreement, dated December 20, 2010, between
Emisphere Technologies, Inc. and Novo Nordisk A/S* |
|||
99.1 | Press Release of Emisphere Technologies, Inc. dated December 21, 2010. |
* | Confidential treatment has been requested for the redacted portions of this agreement. A complete copy of this agreement, including the redacted portions, has been filed separately with the Securities and Exchange Commission. |
Emisphere Technologies, Inc. |
||||
December 21, 2010 | By: | /s/ Michael R. Garone | ||
Name: | Michael R. Garone | |||
Title: | Chief Financial Officer |
Exhibit No. | Description | |||
10.1 | Development and License Agreement, dated December 20, 2010, between
Emisphere Technologies, Inc. and Novo Nordisk A/S* |
|||
99.1 | Press Release of Emisphere Technologies, Inc. dated December 21, 2010. |
* | Confidential treatment has been requested for the redacted portions of this agreement. A complete copy of this agreement, including the redacted portions, has been filed separately with the Securities and Exchange Commission. |